In the past decade, the global perspective to advance radiotherapy and foster collaboration with international partner societies beyond Europe has become increasingly important.
GIRO, under the aegis of ESTRO, is a voluntary collaborative platform with international experts interested in the development of RT globally. Building up on the GTFRCC, HERO and IAEA knowledge base, the ultimate goal is to close the gap in radiotherapy access, globally.
GIRO is responding to the calls to action laid out in the report of the Global Task Force on Radiotherapy for Cancer Control: convened by the Union for International Cancer Control (UICC), the radiotherapy community in the GTFRCC provided a detailed analysis of the current situation worldwide.
GIRO is the next phase of this project: starting from this knowledge base, highlighting the importance of radiotherapy in cancer care, GIRO is a platform of exchange in order to impact on the current situation of radiotherapy worldwide at various levels including access, resources, education, reimbursement, healthcare planning.